Human secreted tau increases amyloid-beta production

被引:173
作者
Bright, Jessica [1 ]
Hussain, Sami [2 ]
Dang, Vu [1 ]
Wright, Sarah [1 ]
Cooper, Bonnie [1 ]
Byun, Tony [2 ]
Ramos, Carla [2 ]
Singh, Andrew [2 ]
Parry, Graham [2 ]
Stagliano, Nancy [1 ,2 ]
Griswold-Prenner, Irene [1 ]
机构
[1] iPierian, Dept Discovery Biol, San Francisco, CA USA
[2] iPierian, Dept Translat Res, San Francisco, CA USA
关键词
Secreted tau; Extracellular tau; eTau; Amyloid-beta (A beta); Neuronal hyperactivity; Alzheimer's disease; Feed forward mechanism; sAPP alpha; PAIRED HELICAL FILAMENTS; PLURIPOTENT STEM-CELLS; ALZHEIMERS-DISEASE; NEUROFIBRILLARY DEGENERATION; ENDOGENOUS TAU; PROTEIN; MOUSE; REDUCTION; TANGLES; CONFORMATION;
D O I
10.1016/j.neurobiolaging.2014.09.007
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The interaction of amyloid-beta (A beta) and tau in the pathogenesis of Alzheimer's disease is a subject of intense inquiry, with the bulk of evidence indicating that changes in tau are downstream of A beta. It has been shown however, that human tau overexpression in amyloid precursor protein transgenic mice increases A beta plaque deposition. Here, we confirm that human tau increases A beta levels. To determine if the observed changes in A beta levels were because of intracellular or extracellular secreted tau (eTau for extracellular tau), we affinity purified secreted tau from Alzheimer's disease patient-derived cortical neuron conditioned media and analyzed it by liquid chromatography-mass spectrometry. We found the extracellular species to be composed predominantly of a series of N-terminal fragments of tau, with no evidence of C-terminal tau fragments. We characterized a subset of high affinity tau antibodies, each capable of engaging and neutralizing eTau. We found that neutralizing eTau reduces A beta levels in vitro in primary human cortical neurons where exogenously adding eTau increases A beta levels. In vivo, neutralizing human tau in 2 human tau transgenic models also reduced A beta levels. We show that the human tau insert sequence is sufficient to cause the observed increase in A beta levels. Our data furthermore suggest that neuronal hyperactivity may be the mechanism by which this regulation occurs. We show that neuronal hyperactivity regulates both eTau secretion and A beta production. Electrophysiological analysis shows for the first time that secreted eTau causes neuronal hyperactivity. Its induction of hyperactivity may be the mechanism by which eTau regulates A beta production. Together with previous findings, these data posit a novel connection between tau and A beta, suggesting a dynamic mechanism of positive feed forward regulation. A beta drives the disease pathway through tau, with eTau further increasing A beta levels, perpetuating a destructive cycle. (C) 2015 The Authors. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:693 / 709
页数:17
相关论文
共 41 条
  • [1] Alzheimer's disease:: intraneuronal alterations precede insoluble amyloid-β formation
    Braak, H
    Del Tredici, K
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 (06) : 713 - 718
  • [2] STAGING OF ALZHEIMERS-DISEASE-RELATED NEUROFIBRILLARY CHANGES
    BRAAK, H
    BRAAK, E
    [J]. NEUROBIOLOGY OF AGING, 1995, 16 (03) : 271 - 278
  • [3] Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid
    Braak, Heiko
    Zetterberg, Henrik
    Del Tredici, Kelly
    Blennow, Kaj
    [J]. ACTA NEUROPATHOLOGICA, 2013, 126 (05) : 631 - 641
  • [4] A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells
    Burkhardt, Matthew F.
    Martinez, Fernando J.
    Wright, Sarah
    Ramos, Carla
    Volfson, Dmitri
    Mason, Michael
    Garnes, Jeff
    Vu Dang
    Lievers, Jeffery
    Shoukat-Mumtaz, Uzma
    Martinez, Rita
    Gai, Hui
    Blake, Robert
    Vaisberg, Eugeni
    Grskovic, Marica
    Johnson, Charles
    Irion, Stefan
    Bright, Jessica
    Cooper, Bonnie
    Leane Nguyen
    Griswold-Prenner, Irene
    Javaherian, Ashkan
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 56 : 355 - 364
  • [5] Constitutive secretion of tau protein by an unconventional mechanism
    Chai, Xiyun
    Dage, Jeffrey L.
    Citron, Martin
    [J]. NEUROBIOLOGY OF DISEASE, 2012, 48 (03) : 356 - 366
  • [6] Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
    Chambers, Stuart M.
    Fasano, Christopher A.
    Papapetrou, Eirini P.
    Tomishima, Mark
    Sadelain, Michel
    Studer, Lorenz
    [J]. NATURE BIOTECHNOLOGY, 2009, 27 (03) : 275 - 280
  • [7] Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo
    Cirrito, John R.
    Kang, Jae-Eun
    Lee, Jiyeon
    Stewart, Floy R.
    Verges, Deborah K.
    Silverio, Luz M.
    Bu, Guojun
    Mennerick, Steven
    Holtzman, David M.
    [J]. NEURON, 2008, 58 (01) : 42 - 51
  • [8] Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
    Cirrito, JR
    Yamada, KA
    Finn, MB
    Sloviter, RS
    Bales, KR
    May, PC
    Schoepp, DD
    Paul, SM
    Mennerick, S
    Holtzman, DM
    [J]. NEURON, 2005, 48 (06) : 913 - 922
  • [9] Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines
    Colombo, Alessio
    Wang, Huanhuan
    Kuhn, Peer-Hendrik
    Page, Richard
    Kremmer, Elisabeth
    Dempsey, Peter J.
    Crawford, Howard C.
    Lichtenthaler, Stefan F.
    [J]. NEUROBIOLOGY OF DISEASE, 2013, 49 : 137 - 147
  • [10] Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
    de Calignon, Alix
    Polydoro, Manuela
    Suarez-Calvet, Marc
    William, Christopher
    Adamowicz, David H.
    Kopeikina, Kathy J.
    Pitstick, Rose
    Sahara, Naruhiko
    Ashe, Karen H.
    Carlson, George A.
    Spires-Jones, Tara L.
    Hyman, Bradley T.
    [J]. NEURON, 2012, 73 (04) : 685 - 697